Secondary Metabolites and Drug Discovery

Umar Ali Dar, Mohd. Shahnawaz, Neha Singh

• Publisher: Wiley-Scrivener
• Year: 2025
• Print ISBN: 9781394204342
• eBook ISBN: 9781394204588
• Edition: 1
• Topic: Medicine
• Subtopic: Pharmacology

This book explores the promising potential of plant and microbe-derived compounds in drug discovery, offering insights into safer alternatives to synthetic drugs and highlighting the vital role of natural products in treating diseases with fewer side effects.

Plants and microbes are a promising source for natural products with the potential to play a major role in drug discovery. Due to advances in the fields of science, technology, engineering, and medicine, the commercial pharmaceutical industry is growing across the globe. Currently, allopathy uses synthetic pharmaceutical drugs for the treatment of diseases, but this practice also exposes patients to significant side effects. Since ancient times, other systems of medicine have been developed that utilize plant-based extracts and molecules to treat various diseases with fewer side effects. While changes in lifestyle, including diet, have had a significant impact on the increased risks of various diseases, there is substantial scientific evidence, both epidemiological and experimental, that vegetables and fruits are key features of diets associated with lower risks of diseases such as cancers and infections. These efforts to identify and create medications from plants are leading to increased manufacturing for larger clinical trials. The continuing scientific research of medicinal plants will undoubtedly provide a wealth of novel, structurally varied, bioactive chemicals. This edited volume provides an overview of various medical systems, with a special focus on microbial and plant-based drug molecules for treating communicable and non-communicable diseases, making it an invaluable resource for researchers, scientists, and practitioners interested in the potential of plant- and microbe-derived secondary metabolites in the ongoing search for innovative, effective, and safer medicines.

Readers will find this book:

• Provides an overview of different types of sources and drug molecules used in allopathic, homeopathic, ayurvedic, Chinese, and Unani systems of medicine;
• Highlights past and current methods of alternative, complementary, folklore, and integrative medicines;
• Discusses the benefits and side effects of the drug molecules used in different systems of medicine at the global level;
• Explores microbial and plant-based drug molecules for treating various communicable and non-communicable diseases.

Audience

Researchers, academics, industry, and governmental experts working in the fields of natural science, natural products, synthetic chemistry, pharmacology, and medicinal chemistry.

Table of contents

• Cover
• Series Page
• Title Page
• Copyright Page
• Dedication Page
• Contents
• Preface
• Acknowledgment
• Chapter 1 Drug Discovery and Secondary Metabolites: An Overview
• Chapter 2 Relationship Between Allopathic Medicine and Secondary Metabolites: Opportunities in Drug Discovery
• Chapter 3 Endophytic Microorganisms in Traditional and Modern Plant-Based Medicine: Diversity, Biomedical Applications, and Future Prospects
• Chapter 4 Historical and Current Scenario of Ayurvedic, Unani, and Chinese Medical Systems
• Chapter 5 Historical and Present Scenario of Folklore System of Medicine, Homeopathic System of Medicine
• Chapter 6 Alternative System of Medicine vs. Traditional System of Medicine
• Chapter 7 Cost, Benefits, and Side Effects of Alternative, Complementary, and Traditional Medicine to Control Non-Communicable Diseases
• Chapter 8 Integrative Medicine: An Overview
• Chapter 9 Different Sources and Types of Drug Molecules Used in Homeopathy System of Medicine
• Chapter 10 Cost, Benefits, and Side Effects of Allopathic Medicine to Control Communicable Diseases
• Chapter 11 Assessing the Value of Allopathic Medicine in Non-Communicable Disease Management: Costs, Benefits, and Side Effects
• Chapter 12 Roles of Allopathic Medicines to Treat SARS-CoV-2 Pathogen Causing COVID-19
• Chapter 13 Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Disease and Drug Development: A Global Approach
• Chapter 14 Costs, Benefits, and Side Effects of Microbial Secondary Metabolites to Control Non-Communicable Diseases
• Chapter 15 Bioactive Plant-Derived Secondary Metabolites in Non-Communicable Disease Management
• Chapter 16 Sources and Types of Secondary Metabolites: An Overview
• Chapter 17 Antidiabetic Activities of Carica papaya L.
• Chapter 18 Phytochemical Analysis and Antioxidant Potential in Six Important Medicinal Plants of Ladakh Trans-Himalaya for Drug Disco
• Chapter 19 Future Research Directions and Prospects of Secondary Metabolites in Drug Discoveries
• Chapter 20 Pharmacological Diversity in Integrative Medicine: Exploring Sources and Approaches to Drug Discovery Utilizing Natural Products
• Index
• EULA